XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 5,353 $ 4,544
Receivables 46 47
Inventories:    
Leaf tobacco 677 744
Other raw materials 179 166
Work in process 30 23
Finished product 328 261
Inventory, net 1,214 1,194
Other current assets 149 298
Total current assets 6,762 6,083
Property, plant and equipment, at cost 4,300 4,432
Less accumulated depreciation 2,753 2,879
Property, plant and equipment, net 1,547 1,553
Goodwill 5,177 5,177
Other intangible assets, net 12,289 12,306
Investments in equity securities ($1,610 million and $1,720 million at March 31, 2022 and December 31, 2021, respectively, measured at fair value) 13,479 13,481
Other assets 981 923
Total Assets 40,235 39,523
Liabilities    
Current portion of long-term debt 2,517 1,105
Accounts payable 379 449
Accrued liabilities:    
Marketing 658 664
Settlement charges 4,229 3,349
Other 1,508 1,365
Dividends payable 1,637 1,647
Total current liabilities 10,928 8,579
Long-term debt 25,405 26,939
Deferred income taxes 3,766 3,692
Accrued pension costs 199 200
Accrued postretirement health care costs 1,438 1,436
Other liabilities 259 283
Total liabilities 41,995 41,129
Contingencies (Note 10)
Stockholders’ Equity (Deficit)    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935 935
Additional paid-in capital 5,848 5,857
Earnings reinvested in the business 30,988 30,664
Accumulated other comprehensive losses (2,962) (3,056)
Cost of repurchased stock (993,749,776 shares at March 31, 2022 and 982,785,699 shares at December 31, 2021) (36,569) (36,006)
Total stockholders’ equity (deficit) (1,760) (1,606)
Total Liabilities and Stockholders’ Equity (Deficit) $ 40,235 $ 39,523